PhRMA

JANUARY 17, 2023

The Inflation Reduction Act’s (IRA’s) drug price setting provisions, as predicted, are already impacting biopharmaceutical research & development (R&D) decisions. Whether you are looking at estimates of how many fewer medicines or indications will be developed, or noting shifts away from areas of unmet patient need because the law is signaling those innovations are not valued, the IRA’s price setting provisions are a loss for patients everywhere.

228

228

Drug Topics

JANUARY 17, 2023

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

Vaccines 179

Vaccines 179

PhRMA

JANUARY 17, 2023

Last summer, the United States and Taiwan launched the U.S.-Taiwan Initiative on 21st-Century Trade to deepen economic and trade relations. In detailed comments to the U.S. Trade Representative (USTR), PhRMA encouraged the Biden administration to pursue an agreement that is as comprehensive and ambitious as possible to the benefit of both American and Taiwanese citizens.

130

130

Drug Topics

JANUARY 17, 2023

The updates include new recommendations for COVID-19 and pneumococcal vaccines.

Immunization 201

Immunization Vaccines 201

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 17, 2023

An app using AI to evaluate blood sugar data, concerning trends, and recommend management tools will be a part of a clinical trial in 2024 for further assessment.

139

139

The Checkup by Singlecare

JANUARY 17, 2023

When most people hear the word meditation, they probably imagine someone sitting perfectly still in a quiet room, legs crossed, zoned out in a state of total bliss. But meditation can be performed in many different ways, and while it does take some practice to get the hang of it, even just a few minutes a day can help reduce some symptoms of common mental health conditions like anxiety and depression.

Communication 123

Communication 123

Drug Topics

JANUARY 17, 2023

A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.

98

98

Pharmacy Times

JANUARY 17, 2023

COVID-19 infection was significantly associated with increased risks of several conditions, including loss of smell and taste, concentration, and memory impairment.

132

132

Drug Topics

JANUARY 17, 2023

The shift in immunization from primary care to pharmacy is your opportunity to improve outcomes and grow your business. Solutions that integrate directly with pharmacy management systems enable clinical decision support at the point of care. The return on investment is significant — in one study, resulting in a 24% increase in revenue per patient encounter.

Immunization 98

Immunization 98

Pharmacy Times

JANUARY 17, 2023

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.

Vaccines 167

Vaccines 167

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JANUARY 17, 2023

Increased injection drug use has led to a spike in cases of the life-threatening heart condition endocarditis , with cases rapidly accelerating since the onset of Covid-19. The increased case count is one of the lesser-known side effects of the deadly addiction epidemic. But patients with endocarditis, an inflammation of the heart lining caused by infection, require complex, thoughtful care — care that the U.S. health system is ill-equipped to provide.

Hospitals 120

Hospitals 120

Pharmacy Times

JANUARY 17, 2023

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

139

139

STAT

JANUARY 17, 2023

Moderna’s vaccine against the respiratory syncytial virus, or RSV, reduced the rate of lower respiratory disease in people over 60 in a Phase 3 trial, the company said Tuesday. The result will increase competition in a soon-to-be crowded market. The drug giants Pfizer and GlaxoSmithKline have already presented results for their RSV vaccines in older individuals, and have been preparing for what could be a brisk marketing battle.

Vaccines 116

Vaccines 116

Pharmacy Times

JANUARY 17, 2023

The vaccine was 88% effective at preventing pertussis among infants younger than 2 months when administered during the third trimester of pregnancy.

Vaccines 123

Vaccines FDA 123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JANUARY 17, 2023

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49.

Vaccines 131

Vaccines 131

Pharmacy Times

JANUARY 17, 2023

The mean annualized bleed rate was reduced by 80% from baseline and Factor VIII usage was reduced by 94% in year 3 compared to baseline.

123

123

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development. It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work.

Hospitals 110

Hospitals Chemotherapy Communication Immunization 110

Pharmacy Times

JANUARY 17, 2023

It is too early to know how patients could potentially change their microbiome to reduce their diabetes risk.

132

132

pharmaphorum

JANUARY 17, 2023

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists detecting lung cancer in chest X-rays. The aim of the pilot is to scan and review more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance, to see if Qure.ai’s qXR software can make faster and more accurate diagnoses of lung cancer.

106

106

Pharmacy Times

JANUARY 17, 2023

The scholarship is accepting applications until February 28, 2023, and 4 pharmacy school students will be announced in April.

123

123

STAT

JANUARY 17, 2023

Catherine was getting nervous about her ADHD prescription. In 2022, the 29-year-old New Yorker had started using Done, a direct-to-consumer telehealth company that treats attention deficit hyperactivity disorder. The medication her provider had prescribed, a stimulant called Vyvanse, was helping her manage distraction so severe that she frequently had car accidents.

Controlled Substances 106

Controlled Substances 106

Drug Store News

JANUARY 17, 2023

In late December, CVS and Rite Aid instituted product limits as cases of COVID-19, flu and RSV ticked up, amid a scarcity of OTC children’s pain relief products at certain retail locations, including Walgreens.

105

105

pharmaphorum

JANUARY 17, 2023

UK digital brain health company Cambridge Cognition has bolstered its speech analysis capabilities with the acquisition of Winterlight Labs of Toronto, Canada, in a cash and stock deal worth £7 million ($8.6 million). The deal extends Cambridge Cognition’s technology in the area of the use of voice-based assessments that can be used to detect and monitor health conditions, and according to the company gives it a platform “that can deliver most of the voice tasks used today by psychol

Immunization 105

Immunization 105

STAT

JANUARY 17, 2023

Two congressional committees recently released damning results of an 18-month investigation into the Food and Drug Administration’s approval of Biogen’s controversial Alzheimer’s drug, Aduhelm. The systems that enabled Biogen’s actions, however, went largely unscrutinized. The report listed extensive and serious concerns about Aduhelm’s rollout, including “atypical” interactions and collaboration between the FDA and Biogen; inappropriate use of th

FDA 104

FDA 104

European Pharmaceutical Review

JANUARY 17, 2023

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. In the data, T cells were revealed as the most commonly investigated cell type continuing to increase. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . Matthew Durdy, Chief Executive of CGT Catapult commented: “It is encouraging to see continued growth of UK clinical trial activity, demonstrating the UK as a favoura

Documentation 101

Documentation 101

STAT

JANUARY 17, 2023

More than two dozen big buyers of prescription medicines expect that prices will rise by an average of 8% annually over the next three years, a slight uptick from a year ago. And 19% believe that a “substantial portion” of the anticipated increases can be attributed to a shift to newer, pricier therapies, which is up from 8% a year ago, a new survey found.

Hospitals 104

Hospitals 104

Fierce Healthcare

JANUARY 17, 2023

In a tough fundraising climate for startups, conversations at JPM 2023 shift to partnerships. hlandi. Tue, 01/17/2023 - 16:11.

121

121

STAT

JANUARY 17, 2023

SAN FRANCISCO — The last time Sana CEO Steve Harr was here for the J.P. Morgan Healthcare Conference, his company had only recently shrugged off the unprintable code name its founders used privately: FD Therapeutics, short for “F— Disease.” Little was known about the then-mysterious cell therapy startup, except that it would pursue ideas “ that will seem unconnected to the current reality ” and, rumor had it, potentially raise an over $1 billion Series A

104

104

Drug Store News

JANUARY 17, 2023

Texans rank pharmacies as the most accessible healthcare destination and support policies that allow patient choice when it comes to accessing services, NACDS said.

104

104

STAT

JANUARY 17, 2023

Most of the largest health plans in the U.S. generally provide “fair access” to 19 treatments for a handful of serious diseases, although transparent coverage information is often lacking for some medicines, a new analysis found. Almost uniformly, the 18 health plans and benefit managers examined make the medications available fairly when judged on three criteria: prescriber restrictions, eligibility based on clinical data, and step therapy, which requires patients to try other med

Insurance 104

Insurance 104

pharmaphorum

JANUARY 17, 2023

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool. Already, it is operating at scale across the company, used in more than 28 countries and available in 62 languages.

98

98

STAT

JANUARY 17, 2023

In another bid to widen access to its medical products, Pfizer plans to provide roughly 500 medicines and vaccines — many of which are no longer protected by patents — at not-for-profit prices t0 45 mostly low-income countries. The goal is to make it possible for the countries to purchase the drugs and vaccines at substantially lower prices than they might otherwise.

Vaccines 102

Vaccines 102

Pharmafile

JANUARY 17, 2023

Thermo Fisher Scientific has announced that it has become a founding sponsor of Momentum Labs in Alachua, Florida, US. The company has taken on this role in an attempt to support emerging biotechnology companies, and Momentum Labs aims to work as a collaborative laboratory and office space for a variety of expanding biotechs in the region. read more.

Communication 97

Communication 97

STAT

JANUARY 17, 2023

The Blueprint for an AI Bill of Rights the White House recently published didn’t come a moment too soon for the health care industry. The number of health care-related artificial intelligence models on the market has increased steadily over the past decade, with the health care AI market expected to grow from $7 billion today to $67 billion in 2027.

100

100